Home » Stocks » EAR

Eargo, Inc. (EAR)

Stock Price: $61.69 USD -1.31 (-2.08%)
Updated Jan 25, 2021 3:05 PM EST - Market open
Market Cap 2.41B
Revenue (ttm) 46.94M
Net Income (ttm) -43.83M
Shares Out 36.33M
EPS (ttm) -1.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 25
Last Price $61.69
Previous Close $63.00
Change ($) -1.31
Change (%) -2.08%
Day's Open 63.05
Day's Range 56.57 - 63.70
Day's Volume 232,033
52-Week Range 33.49 - 63.70

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

SAN JOSE, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced...

GlobeNewsWire - 1 month ago

SAN JOSE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announce...

GlobeNewsWire - 1 month ago

Eargo is also named to “Best Company for Women” and “Best CEOs” list Eargo is also named to “Best Company for Women” and “Best CEOs” list

Business Wire - 1 month ago

LONDON--(BUSINESS WIRE)--Deep Pharma Intelligence names Nanox Imaging (NASDAQ:NNOX), TransMedics, Inc. (NASDAQ: TMDX), Outset Medical, Inc. (NASDAQ:OM), Eargo, Inc. (NASDAQ:EAR), and Silk Road...

Other stocks mentioned: NNOX, OM, SILK, TMDX
GlobeNewsWire - 2 months ago

Net revenues of $18.2 million, up 135.3% year-over-year

GlobeNewsWire - 2 months ago

SAN JOSE, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Eargo Inc., (NASDAQ: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced...

About EAR

Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss. We developed the Eargo solution to create a hearing aid that consumers actually want to use. Our innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA regulated, exempt Class I device for the treatment of hearing loss. Ou... [Read more...]

Industry
Medical Devices
IPO Date
Oct 16, 2020
CEO
Christian Gormsen
Employees
214
Stock Exchange
NASDAQ
Ticker Symbol
EAR
Full Company Profile

Financial Performance

In 2019, Eargo's revenue was $32.79 million, an increase of 41.56% compared to the previous year's $23.16 million. Losses were -$44.49 million, 31.6% more than in 2018.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Eargo stock is "Strong Buy." The 12-month stock price forecast is 52.33, which is a decrease of -15.17% from the latest price.

Price Target
$52.33
(-15.17% downside)
Analyst Consensus: Strong Buy